QT interval and QT dispersion in systemic sclerosis (scleroderma)

Journal of Internal Medicine

Volumn 243, Issue 2, 1998, Pages 127-132

  Sgreccia, A ^a   Morelli, S ^a   Ferrante, L ^a   Perrone, C ^a   De Marzio, P ^a   De Vincentiis, G ^b   Scopinaro, F ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Heart rate variability; QT interval; Systemic sclerosis

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; ARTICLE; CALCULATION; CONTROLLED STUDY; DISPERSION; ELECTROCARDIOGRAM; FEMALE; HEART MUSCLE PERFUSION; HEART RATE VARIABILITY; HEART SCINTISCANNING; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; SYSTEMIC SCLEROSIS;

EID: 0031981655     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Medsger TA Jr, Masi AT. Survival with scleroderma II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients. J Chronic Dis 1973; 26: 647-60.
2. Wynn J, Fineberg N, Matzer L, Cortada X, Armstrong W, Dillon JC et al. Prediction of survival in progressive systemic sclerosis by multivariate analysis of clinical features. Am Heart J 1985; 110: 123-7.
3. Kostis JB, Seibold JR, Turkeivich D, Masi AT, Grau RG, Medsger TA Jr et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988; 84: 1007-15.
4. Schwartz PJ, Wolf S. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978; 57: 1074-7.
5. Ahnve S, Gilpin E, Madsen EB, Froelicher V, Henning H, Ross J. Prognostic importance of QTc interval at discharge after acute myocardial infarction: a multicenter study of 865 patients. Am Heart J 1984; 108: 395-400.
6. Peters RW, Barker A, Byington R for the BHAT study group. Prognostic value of QTc prolongation. The BHAT experience. Circulation 1984; 70: 4 (abstract).
7. Algra A, Tijssen JGP, Roelandt JRTC, Pool J, Lubsen J. QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 1991; 83: 1888-94.
8. Schouten EG, Dekker JM, Meppelink P, Kok FJ, Vandenbroucke JP, Pool J. QT-interval prolongation predicts cardiovascular mortality in an apparently healthy population. Circulation 1991; 84: 1516-23.
9. Linker NJ, Colonna P, Kekwick CA, Till J, Camm AJ, Ward DE. Assessment of QT dispersion in patients with congenital long QT syndromes. Am J Cardiol 1992; 69: 634-8.
10. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 1994; 343: 327-9.
11. Glancy JM, Garratt CJ, Woods KL, de Bono DP. QT dispersion and mortality after myocardial infarction. Lancet 1995; 345: 945-8.
12. Perkiömäki JS, Koistinen J, Yli-Mäyry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995; 26: 174-9.
13. Laakso M, Aberg A, Savola J, Pentikäinen PJ, Pyörälä K. Diseases and drugs causing prolongation of the QT interval. Am J Cardiol 1987; 59: 862-5.
14. Hu JTY, Wyse DG, Gillis AM, Duff HJ, Solyo MA, Mitchell LB. Precordial QT interval dispersion as a marker of torsades de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992; 86: 1376-82.
15. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993; 72: 973-6.
16. Schwartz PJ, Stone HL, Brown AM. Effects of unilateral stellate ganglion blockade on the arrhythmias associated with coronary occlusion. Am Heart J 1976; 92: 589-95.
17. Schwartz PJ, Snebold NG, Brown AM. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold. Am J Cardiol 1976; 37: 1034-9.
18. Schwartz PJ, Locati EH, Moss AJ, Crampton RS, Trazzi R, Ruberti U. Left cardiac sympathetic denervation in the therapy of congenital long QT syndrome - a worldwide report. Circulation 1991; 84: 503-11.
19. Dorian P, Newman D, Hughes W, Langer A, Freeman M. Torsades de pointes ventricular tachycardia following right pneumonectomy: Insight into the relation between right cardiac sympathetic nerve damage, QT intervals and arrhythmias, Int J Cardiol 1994; 46: 292-6.
20. Moss AJ, Schwartz PJ. Delayed repolarization (QT or QTU prolongation) and malignant ventricular arrhythmias. Mod Concepts Cardiovasc Dis 1982; 51: 85-90.
21. Wei K, Dorian P, Newman D, Langer A. Association between QT dispersion and autonomic dysfunction in patients with diabetes mellitus. J Am Coll Cardiol 1995; 26: 859-63.
22. Bexton RS, Vallin HO, Camm AJ. Diurnal variation of the QT interval - influence of the autonomic nervous system. Br Heart J 1986; 55: 253-8.
23. Lo SSS, Mathias CJ, St John Sutton M. QT interval and dispersion in primary autonomic failure. Heart 1996; 75: 498-501.
24. Klimiuk PS, Taylor L, Baker RD, Jason MIV. Autonomic neuropathy in systemic sclerosis. Ann Rheum Dis 1988; 47: 542-5.
25. Dessein PH, Joffe BI, Metz RM, Millar DL, Lawson M, Stanwix A. Autonomic dysfunction in systemic sclerosis: sympathetic overactivity and instability. Am J Med 1992; 93: 143-50.
26. Morelli S, Sgreccia A, Ferrante L, Barbieri C, Bernardo ML, Perrone C et al. Relationships between electrocardiographic and echocardiographic findings in systemic sclerosis (scleroderma). Int J Cardiol 1996; 57: 151-6.
27. Bigger JT, Albrecht P, Steinman RC, Rolnitzky LM, Fleiss JL, Cohen RJ. Comparison of time- and frequency domain-based measures of cardiac parasympathetic activity in Holter recordings after myocardial infarction. Am J Cardiol 1989; 64: 536-8.
28. Casolo G, Balli E, Taddei T, Amuhasi J, Gori C. Decreased spontaneous heart rate variability in congestive heart failure. Am J Cardiol 1989; 64: 1162-7.
29. Sands KEF, Appel ML, Lilly LS, Schoen FJ, Mudge GH, Cohen RJ. Power spectrum analysis of heart rate variability in human cardiac transplant recipients. Circulation 1989; 79: 76-82.
30. Malpas SC, Maling TJ, Heart rate variability and cardiac autonomic function in diabetes. Diabetes 1990; 39: 1177-81.
31. Breuer H-WM, Skyschally A, Schulz R, Martin C, Wehr M, Heusch G. Heart rate variability and circulating catecholamine concentrations during steady state exercise in healthy volunteers. Br Heart J 1993; 70: 144-9.
32. Pagani M, Mazzuero G, Ferrari A, Liberati D, Cerutti S, Vaitl D et al. Sympathovagal interaction during mental stress: a study employing spectral analysis of heart rate variability in healthy controls and in patients with a prior myocardial infarction. Circulation Supplement 1991; 83 (Suppl. II): 43-51.
33. Pagani M, Lombardi F, Guzzetti S, Rinaldi O, Furlan R, Pizzinelli P et al. Power spectral analysis of heart rate and arterial pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res 1986; 59: 178-93.
34. Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985; 248: H151-3.
35. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-90.
36. LeRoy EC. The heart in systemic sclerosis. N Engl J Med 1982; 310: 188-90.
37. Bazzett HC. An analysis of time-relations of electrocardiograms. Heart 1918; 7: 353-70.
38. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurements, physiological interpretation, and clinical use. Circulation 1996; 93: 1043-65.
39. D'Angelo WA, Fries JF, Masi AT, Shulman LE. Pathologic observations in systemic sclerosis (scleroderma): a study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969; 46: 428-40.
40. Follansbee WP, Miller TR, Curtiss EI, Orie JE, Bernstein RL, Kiernan JM et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990; 17: 656-62.
41. Bulkley BH, Ridolfi RL, Salyer WR, Hutechins GM. Myocardial lesions of progressive systemic sclerosis. Circulation 1976; 53: 483-90.
42. Follansbee WR, Curtiss EI, Ranhko PS, Medsger TA Jr, Lavine SJ, Owens GR et al. The electrocardiogram in systemic sclerosis (scleroderma). Am J Med 1989; 79: 183-92.
43. Morelli S, Piccirillo G, Fimognari F, Sgreccia A, Ferrante L, Morabito G et al. Twenty-four hour heart rate period variability in systemic sclerosis (scleroderma). J Rheumatol 1996; 23: 643-5.
44. Bigger JT Jr, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol 1993; 21: 729-36.
45. Myers GA, Martin GJ, Magid NM, Barnett PS, Schaad JW, Weiss JS et al. Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods. IEEE Trans Biomed Eng 1986; 33: 1149-56.